Your browser doesn't support javascript.
loading
AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical Trial.
Ivashchenko, Andrey A; Dmitriev, Kirill A; Vostokova, Natalia V; Azarova, Valeria N; Blinow, Andrew A; Egorova, Alina N; Gordeev, Ivan G; Ilin, Alexey P; Karapetian, Ruben N; Kravchenko, Dmitry V; Lomakin, Nikita V; Merkulova, Elena A; Papazova, Natalia A; Pavlikova, Elena P; Savchuk, Nikolay P; Simakina, Elena N; Sitdekov, Tagir A; Smolyarchuk, Elena A; Tikhomolova, Elena G; Yakubova, Elena V; Ivachtchenko, Alexandre V.
Afiliación
  • Ivashchenko AA; ChemRar High-Tech Center, Khimki, Moscow region, Russian Federation.
  • Dmitriev KA; Russian Direct Investment Fund, Moscow, Russian Federation.
  • Vostokova NV; IPHARMA LLC, Skolkovo Innovative Centre, Moscow, Russian Federation.
  • Azarova VN; IPHARMA LLC, Skolkovo Innovative Centre, Moscow, Russian Federation.
  • Blinow AA; Chromis LLC, Skolkovo Innovative Centre, Moscow, Russian Federation.
  • Egorova AN; IPHARMA LLC, Skolkovo Innovative Centre, Moscow, Russian Federation.
  • Gordeev IG; City Clinical Hospital n.a. O.M. Filatov, Moscow, Russian Federation.
  • Ilin AP; Department of Chemistry and Technology, Chemical Diversity Research Institute, Khimki, Moscow region, Russian Federation.
  • Karapetian RN; Department of Biology, Chemical Diversity Research Institute, Khimki, Moscow region, Russian Federation.
  • Kravchenko DV; Department of Chemistry and Technology, Chemical Diversity Research Institute, Khimki, Moscow region, Russian Federation.
  • Lomakin NV; Central Clinical Hospital with Polyclinic, Moscow, Russian Federation.
  • Merkulova EA; IPHARMA LLC, Skolkovo Innovative Centre, Moscow, Russian Federation.
  • Papazova NA; Department of Finished Dosage Forms, Chemical Diversity Research Institute, Khimki, Moscow region, Russian Federation.
  • Pavlikova EP; Moscow State University n.a. M. V. Lomonosov, Moscow, Russian Federation.
  • Savchuk NP; Chemical Diversity Research Institute, Khimki, Moscow region, Russian Federation.
  • Simakina EN; Clinical Hospital No.1, Smolensk, Russian Federation.
  • Sitdekov TA; Russian Direct Investment Fund, Moscow, Russian Federation.
  • Smolyarchuk EA; First Moscow State Medical University n.a. I.M. Sechenov, Moscow, Russian Federation.
  • Tikhomolova EG; Infectious clinical hospital No. 2, Nizhny Novgorod, Russian Federation.
  • Yakubova EV; Chromis LLC, Skolkovo Innovative Centre, Moscow, Russian Federation.
  • Ivachtchenko AV; Chemical Diversity Research Institute, Khimki, Moscow region, Russian Federation.
Clin Infect Dis ; 73(3): 531-534, 2021 08 02.
Article en En | MEDLINE | ID: mdl-32770240
ABSTRACT
In May 2020 the Russian Ministry of Health granted fast-track marketing authorization to RNA polymerase inhibitor AVIFAVIR (favipiravir) for the treatment of COVID-19 patients. In the pilot stage of Phase II/III clinical trial, AVIFAVIR enabled SARS-CoV-2 viral clearance in 62.5% of patients within 4 days, and was safe and well-tolerated. Clinical Trials Registration. NCT04434248.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2021 Tipo del documento: Article Pais de publicación: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2021 Tipo del documento: Article Pais de publicación: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA